Silva Clovis A.

Podsumowanie dorobku w bazie danych

3
publikacji (2013–2019)
12,384
łączny Impact Factor
45
łącznie punktów MNiSW

Identyfikatory

BPP ID
29549

Publikacje w latach

10

Punkty MNiSW w latach

45,000

Impact Factor w latach

12,3840

Statystyki wg charakteru

Charakter formalnyLiczba prac
2
1
Razem3

Najczęstsi współautorzy

  • (3)
  • (3)
  • (3)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
Zobacz pełną sieć powiązań

Wyszukaj publikacje autora

Bez zaznaczonych filtrów wyszukiwanie pokaże wszystkie prace autora. Zaznacz typy, lata lub jednostki, żeby zawęzić wyniki.

Typ publikacji
Lata
Jednostki

Najlepsze prace (punkty MNiSW)

  1. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351

Najlepsze prace (Impact Factor)

  1. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351

Najnowsze artykuły

  1. American college of rheumatology provisional criteria for clinically relevant improvement in children and adolescents with childhood-onset systemic lupus erythematosus. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] MICHAEL J. HOLLAND, MICHAEL W. BERESFORD, STACY P. ARDOIN, SIMONE APPENZELLER, CLOVIS A. SILVA, FRANCISCO FLORES, BEATRICE GOILAV, PINAR O. A. AYDIN, SCOTT E. WENDERFER, DEBORAH M. LEVY, ANGELO RAVELLI, RAJU KHUBCHANDANI, TADEJ AVCIN, MARISA S. KLEIN‐GITELMAN, NICOLINO RUPERTO, BRIAN M. FELDMAN, JUN YING, THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIAL ORGANISATION, PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP [M. IN.], VIOLETTA OPOKA-WINIARSKA. Arthritis Care Res. 2019 vol. 71 nr 5 s. 579-590, bibliogr. DOI: 10.1002/acr.23834
  2. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351

Ostatnio edytowane

  1. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351
  2. Efficacy and safety of tocilizumab in polyarticular juvenile idiopathic arthritis: CHERISH results at week 40. [AUT.] EILEEN BAILDAM, NICOLINO RUPERTO, HERMINE BRUNNER, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, RUBEN J. CUTTICA, VLADIMIR KELTSEV, RICARDO XAVIER, INMACULADA C. PENADES, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEKSEEVA, VYACHESLAV CHASNYK, JOSE CHAVEZ, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL D. SILVERMAN, ALBERTO SPINDLER, DANIEL J. LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI. Rheumatology (Oxford) 2013 vol. 52 supl. 1 s. i35, Rheumatology 2013. 23-25 April, 2013. Abstr.
  3. American college of rheumatology provisional criteria for clinically relevant improvement in children and adolescents with childhood-onset systemic lupus erythematosus. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] MICHAEL J. HOLLAND, MICHAEL W. BERESFORD, STACY P. ARDOIN, SIMONE APPENZELLER, CLOVIS A. SILVA, FRANCISCO FLORES, BEATRICE GOILAV, PINAR O. A. AYDIN, SCOTT E. WENDERFER, DEBORAH M. LEVY, ANGELO RAVELLI, RAJU KHUBCHANDANI, TADEJ AVCIN, MARISA S. KLEIN‐GITELMAN, NICOLINO RUPERTO, BRIAN M. FELDMAN, JUN YING, THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIAL ORGANISATION, PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP [M. IN.], VIOLETTA OPOKA-WINIARSKA. Arthritis Care Res. 2019 vol. 71 nr 5 s. 579-590, bibliogr. DOI: 10.1002/acr.23834